Annegien Broeks

Active 1993–2025

106
Papers
26,593
Citations
71
h-index
101
i10-index

Citations

Citations per year for Annegien Broeks1971: 1 citations1994: 4 citations1995: 11 citations1996: 10 citations1997: 13 citations1998: 24 citations1999: 26 citations2000: 19 citations2001: 25 citations2002: 18 citations2003: 17 citations2004: 23 citations2005: 20 citations2006: 23 citations2007: 46 citations2008: 45 citations2009: 44 citations2010: 73 citations2011: 101 citations2012: 141 citations2013: 281 citations2014: 264 citations2015: 270 citations2016: 356 citations2017: 375 citations2018: 359 citations2019: 998 citations2020: 1,194 citations2021: 1,151 citations2022: 958 citations2023: 873 citations2024: 1,182 citations2025: 592 citations2026: 13 citations1972–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,375 citing papers, 19.8% of this breakdownChina: 1,542 citing papers, 9% of this breakdownUnited Kingdom: 1,367 citing papers, 8% of this breakdownNetherlands: 857 citing papers, 5% of this breakdownGermany: 844 citing papers, 4.9% of this breakdownAustralia: 698 citing papers, 4.1% of this breakdownCanada: 683 citing papers, 4% of this breakdownItaly: 650 citing papers, 3.8% of this breakdownFrance: 632 citing papers, 3.7% of this breakdownSpain: 496 citing papers, 2.9% of this breakdownSweden: 489 citing papers, 2.9% of this breakdownDenmark: 320 citing papers, 1.9% of this breakdown
0%19.8%Other 30%

Fields

  • Medicine46.8%
  • Biochemistry, Genetics and Molecular Biology44.8%
  • Immunology and Microbiology3.3%
  • Computer Science0.9%
  • Agricultural and Biological Sciences0.8%
  • Engineering0.7%
  • Other2.7%

Topics

  • Cancer Immunotherapy and Biomarkers6.7%
  • Cancer Genomics and Diagnostics5%
  • BRCA gene mutations in cancer4%
  • Genetic Associations and Epidemiology2.8%
  • Immunotherapy and Immune Responses2.7%
  • Genetic factors in colorectal cancer2.5%
  • Other76.3%

Coauthors

All papers

Open in search
  1. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 1,388

  2. Landscape of somatic mutations in 560 breast cancer whole-genome sequences

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerrit K. Hooijer, Se Jin Jang, David Jones, Hyung-Yong Kim, Tari King, Savitri Krishnamurthy, Hee Jin Lee, Jeong‐Yeon Lee, Yilong Li, Stuart McLaren, Andrew Menzies, Ville Mustonen, Sarah O’Meara, Iris Pauporté, Xavier Pivot, Colin A. Purdie, Keiran Raine, Kamna Ramakrishnan, F. Germán Rodríguez-González, Gilles Romieu, Anieta M. Sieuwerts, Peter T. Simpson, Rebecca Shepherd, Lucy Stebbings, Olafur A. Stefansson, Jon W. Teague, Stefania Tommasi, Isabelle Treilleux, Gert G. Van den Eynden, Peter Vermeulen, Anne Vincent‐Salomon, Lucy Yates, Carlos Caldas, Laura van’t Veer, Andrew Tutt, Stian Knappskog, Benita Kiat Tee Tan, Jos Jonkers, Åke Borg, Naoto T. Ueno, Christos Sotiriou, Alain Viari, P. Andrew Futreal, Peter J. Campbell, Paul N. Span, Steven Van Laere, Sunil R. Lakhani, Jorunn E. Eyfjord, Alastair M. Thompson, Ewan Birney, Hendrik G. Stunnenberg, Marc J. van de Vijver, John W.M. Martens, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Gu Kong, Gilles Thomas, Michael R. Stratton - Nature 2016 cited by 2,382

  3. Association analysis identifies 65 new breast cancer risk loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Habibul Ahsan, Kristiina Aittomäki, Hoda Anton‐Culver, Natalia Antonenkova, Volker Arndt, Kristan J. Aronson, Banu Arun, Paul L. Auer, François Bacot, Myrto Barrdahl, Caroline Baynes, Matthias W. Beckmann, Sabine Behrens, Javier Benı́tez, Marina Bermisheva, Leslie Bernstein, Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Anne‐Lise Børresen‐Dale, Judith S. Brand, Hiltrud Brauch, Paul Brennan, Hermann Brenner, Louise A. Brinton, Per Broberg, Ian W. Brock, Annegien Broeks, Angela Brooks‐Wilson, Sara Y. Brucker, Thomas Brüning, Barbara Burwinkel, Katja Butterbach, Qiuyin Cai, Hui Cai, Trinidad Caldés, Federico Canzian, Ángel Carracedo, Brian D. Carter, Jose E. Castelao, Tsun Leung Chan, Ting‐Yuan David Cheng, Kee Seng Chia, Ji‐Yeob Choi, Hans Christiansen, Christine L. Clarke, NBCS Collaborators, Margriet Collée, Don Conroy, Emilie Cordina‐Duverger, Sten Cornelissen, David G. Cox, Angela Cox, Simon S. Cross, Julie M. Cunningham, Kamila Czene, Mary B. Daly, Peter Devilee, Kimberly F. Doheny, Thilo Dörk, Isabel dos‐Santos‐Silva, Martine Dumont, Lorraine Durcan, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, A. Heather Eliassen, Carolina Ellberg, Mingajeva Elvira and 262 more - Nature 2017 cited by 1,598

  4. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 855

  5. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 369

  6. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian U. Blank, Jan Paul de Boer, John B.A.G. Haanen, Charlotte L. Zuur - Nature Communications 2021 cited by 336

  7. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 397

  8. A pan-cancer analysis of the microbiome in metastatic cancer

    Authors: , , , , , , , , , , , , , , , , , - Cell 2024 cited by 205

  9. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 714

  10. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ton N. Schumacher, Alexander M. Menzies, Georgina V. Long, Christian U. Blank - Nature Medicine 2021 cited by 337

  11. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Davide Bondavalli, Åke Borg, Hiltrud Brauch, Hermann Brenner, Ignacio Briceño, Annegien Broeks, Sara Y. Brucker, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Helen Byers, Trinidad Caldés, Maria A. Caligo, Mariarosaria Calvello, Daniele Campa, Jose E. Castelao, Jenny Chang‐Claude, Stephen J. Chanock, Melissa Christiaens, Hans Christiansen, Wendy K. Chung, Kathleen Claes, Christine L. Clarke, Sten Cornelissen, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Peter Devilee, Orland Dı́ez, Susan M. Domchek, Thilo Dörk, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Lenka Foretová, Florentia Fostira, Eitan Friedman, Debra Frost, Manuela Gago-Domínguez, Susan M. Gapstur, Judy E. Garber, José Á. García-Sáenz, Mia M. Gaudet, Simon A. Gayther, Graham G. Giles, Andrew K. Godwin, Mark S. Goldberg, David E. Goldgar, Anna González‐Neira, Mark H. Greene, Jacek Gronwald, Pascal Guénel, Lothar Häberle, Eric Hahnen, Christopher A. Haiman, Christopher R. Hake, Per Hall, Ute Hamann, Elaine F. Harkness, Bernadette A. M. Heemskerk‐Gerritsen, Peter Hillemanns and 176 more - Nature Genetics 2020 cited by 567

  12. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Winan J. van Houdt, Daniel S. Peeper, Andrew J. Spillane, Johan Hansson, Ton N. Schumacher, Georgina V. Long, Christian U. Blank - The Lancet Oncology 2019 cited by 522

  13. The landscape of cancer genes and mutational processes in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas F. Easton, Anita Langerød, Ming Ta Michael Lee, Chen‐Yang Shen, Benita Tan Kiat Tee, Bernice Wong Huimin, Annegien Broeks, Ana Cristina Vargas, Gulisa Turashvili, John W.M. Martens, Aquila Fatima, Penelope Miron, Suet‐Feung Chin, Gilles Thomas, Sandrine Boyault, Odette Mariani, Sunil R. Lakhani, Marc J. van de Vijver, Laura van ‘t Veer, John A. Foekens, Christine Desmedt, Christos Sotiriou, Andrew Tutt, Carlos Caldas, Jorge S. Reis‐Filho, Samuel Aparício, Anne Vincent‐Salomon, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Peter J. Campbell, P. Andrew Futreal, Michael R. Stratton - Nature 2012 cited by 1,731

  14. IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2023 cited by 74

  15. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul J. van Diest, Marjanka K. Schmidt, Marleen Kok, Gwen M.H.E. Dackus, Roberto Salgado, Sabine C. Linn - Journal of Clinical Oncology 2022 cited by 144

  16. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. J. van Diest - 2022 cited by 103

  17. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanne Meijers‐Heijboer, Muriel A. Adank, Rob B. van der Luijt, Rebecca Hein, Norbert Dahmen, L. Beckman, Alfons Meindl, Rita K. Schmutzler, Bertram Müller‐Myhsok, Peter Lichtner, John L. Hopper, Melissa C. Southey, Enes Makalic, Daniel F. Schmidt, André G. Uitterlinden, Albert Hofman, David J. Hunter, Stephen J. Chanock, Daniel Vincent, François Bacot, Daniel C. Tessier, Sander Canisius, Lodewyk F.A. Wessels, Christopher A. Haiman, Mitul Shah, Robert Luben, Judith Brown, Craig Luccarini, Nils Schoof, Keith Humphreys, Jingmei Li, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Fergus J. Couch, Xianshu Wang, Celine M. Vachon, Kristen N. Stevens, Diether Lambrechts, Matthieu Moisse, Robert Paridaens, Marie‐Rose Christiaens, Anja Rudolph, Stefan Nickels, Dieter Flesch‐Janys, Nichola Johnson, Zoe Aitken, Kirsimari Aaltonen, Tuomas Heikkinen, Annegien Broeks, Laura J. van’t Veer, C. Ellen van der Schoot, Pascal Guénel, Thérèse Truong, Pierre Laurent‐Puig, F. Ménégaux, Frederik Marmé, Andreas Schneeweiß, Christof Sohn, Barbara Burwinkel, M. Pilar Zamora, José Ignacio Arias Pérez, Guillermo Pita, M. Rosario Alonso, Angela Cox, Ian W. Brock, Simon S. Cross, Malcolm Reed, Elinor J. Sawyer, Ian Tomlinson and 122 more - Nature Genetics 2013 cited by 1,105

  18. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jenny Chang‐Claude, Dieter Flesch‐Janys, Anja Rudolph, Ursula Eilber, Sabine Behrens, Heli Nevanlinna, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Sofia Khan, Kirsimari Aaltonen, Habibul Ahsan, Muhammad G. Kibriya, Alice S. Whittemore, Esther M. John, Kathleen E. Malone, Marilie D. Gammon, Regina M. Santella, Giske Ursin, Enes Makalic, Daniel F. Schmidt, Graham Casey, David J. Hunter, Susan M. Gapstur, Mia M. Gaudet, W. Ryan Diver, Christopher A. Haiman, Fredrick R. Schumacher, Brian E. Henderson, Loı̈c Le Marchand, Christine D. Berg, Stephen J. Chanock, Jonine D. Figueroa, Robert N. Hoover, Diether Lambrechts, Patrick Neven, Hans Wildiers, Erik Van Limbergen, Marjanka K. Schmidt, Annegien Broeks, Senno Verhoef, Sten Cornelissen, Fergus J. Couch, Janet E. Olson, Emily Hallberg, Celine M. Vachon, Quinten Waisfisz, Hanne Meijers‐Heijboer, Muriel A. Adank, Rob B. van der Luijt, Jingmei Li, Jianjun Liu, Keith Humphreys, Daehee Kang, Ji‐Yeob Choi, Sue K. Park, Keun-Young Yoo, Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, Kazuo Tajima, Pascal Guénel, Thérèse Truong, Claire Mulot, Marie Sanchez, Barbara Burwinkel, Frederik Marmé, Harald Surowy, Christof Sohn, Anna H. Wu and 148 more - Nature Genetics 2015 cited by 634

  19. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minouk J. Schoemaker, Jonine D. Figueroa, Stephen J. Chanock, Louise A. Brinton, Jolanta Lissowska, Fergus J. Couch, Janet E. Olson, Celine M. Vachon, V. Shane Pankratz, Diether Lambrechts, Hans Wildiers, Chantal Van Ongeval, Erik Van Limbergen, Vessela Kristensen, Grethe Grenaker Alnæs, Silje Nord, Anne‐Lise Børresen‐Dale, Heli Nevanlinna, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Jenny Chang‐Claude, Anja Rudolph, Petra Seibold, Dieter Flesch‐Janys, Peter A. Fasching, Lothar Haeberle, Arif B. Ekici, Matthias W. Beckmann, Barbara Burwinkel, Frederik Marmé, Andreas Schneeweiß, Christof Sohn, Amy Trentham‐Dietz, Polly A. Newcomb, Linda Titus, Kathleen M. Egan, David J. Hunter, Sara Lindström, Rulla M. Tamimi, Peter Kraft, Nazneen Rahman, Clare Turnbull, Anthony Renwick, Sheila Seal, Jingmei Li, Jianjun Liu, Keith Humphreys, Javier Benı́tez, M. Pilar Zamora, José Ignacio Arias Pérez, Primitiva Menéndez, Anna Jakubowska, Jan Lubiński, Katarzyna Jaworska–Bieniek, Katarzyna Durda, Natalia Bogdanova, Natalia Antonenkova, Thilo Dörk, Hoda Anton‐Culver, Susan L. Neuhausen, Argyrios Ziogas, Leslie Bernstein, Peter Devilee, Robert A.E.M. Tollenaar, Caroline Seynaeve, Christi J. van Asperen, Angela Cox, Simon S. Cross, Malcolm Reed and 112 more - JNCI Journal of the National Cancer Institute 2015 cited by 566

  20. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2015 cited by 265

  21. Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 69

  22. Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William F. Anderson, Angela Cox, Simon S. Cross, Malcolm Reed, Elena Provenzano, Sarah‐Jane Dawson, Alison M. Dunning, Manjeet K. Humphreys, Douglas F. Easton, Montserrat García‐Closas, Carlos Caldas, Paul D.P. Pharoah, David G. Huntsman - PLoS Medicine 2010 cited by 1,150

  23. Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma

    Authors: , , , , , , , , , , , , , - Nature Medicine 2023 cited by 47

  24. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer

    Authors: , , , , , , , , , , , , , , , , - Frontiers in Immunology 2021 cited by 40